Viva Biotech Holdings - Company Profile

Powered by

All the data and insights you need on Viva Biotech Holdings in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Viva Biotech Holdings Strategy Report

  • Understand Viva Biotech Holdings position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Viva Biotech Holdings: Overview

Select Item

Viva Biotech Holdings (Viva Biotech) is a contract research biotech company that offers preclinical drug discovery services. The company provides services such as gene-to-protein and gene-to-structure, viva engine for lead discovery, membrane protein targeted discovery technology, medicinal chemistry, in vitro pharmacology and antibody discovery services. It offers cell lines, crystal structures, GPCR proteins and protein products. The company offers mouse monoclonal antibody generation with an advanced hybridoma platform, protein engineering, epitope mapping, antibody humanization and affinity maturation. It serves to pharmaceutical and biotech industries. Viva Biotech is headquartered in Shanghai, China.

 Gain a 360-degree view of Viva Biotech Holdings and make more informed decisions for your business Gain a 360-degree view of Viva Biotech Holdings and make more informed decisions for your business Find out more
Headquarters China
Address 735 Ziping Road, Zhoupu Town, Pudong New District, Shanghai, 201318
Website www.vivabiotech.com
Telephone 86 21 60893288
No of Employees 2,271
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 1873 (HKG)
Revenue (2022) $353.7M 13.1% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -283.8% (2022 vs 2021)
Market Cap* $121.3M
Net Profit Margin (2022) XYZ -262.5% (2022 vs 2021)
* As of and is in US$
View Viva Biotech Holdings financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Viva Biotech Holdings premium industry data and analytics

1

Pipeline Drugs

Identify which of Viva Biotech Holdings’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Viva Biotech Holdings’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
Cell Lines Gene-To-Protein and Gene-To-Structure
Crystal Structures Viva Engine for Lead Discovery
Proteins Membrane Protein Targeted Discovery Technology
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Viva Biotech Holdings portfolio and identify potential areas for collaboration Understand Viva Biotech Holdings portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In November, the company secured a US$210 million investment from Temasek, Highlight Capital, and True Light.
2023 Contracts/Agreements In June, the company signed an agreement to sell a stake to HighLight Capital.
2021 Contracts/Agreements In October, the company signed a new partnership agreement with NanoImaging Services to provide clients with a streamlined, cryoEM enabled gene to structure workflow.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Viva Biotech Holdings Beijing Kawin Technology Share-Holding Co Ltd China National Biotec Group Dalian Hissen Bio-pharm Co Ltd Rundo International Pharmaceutical Research & Development Co Ltd
Headquarters China China China China China
City Shanghai Beijing Beijing Dalian Shanghai
State/Province Shanghai Beijing Beijing Liaoning Shanghai
No. of Employees 2,271 681 1,000 - -
Entity Type Public Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Mao Chen Cheney Chairman; Chief Executive Officer Executive Board 2018 61
Ren Delin Director; President Executive Board 2018 63
Wu Ying Executive Vice President; Director Executive Board 2009 60
Wang Zheren Chief Financial Officer Senior Management 2021 39
Cheng Xueheng Chief Technology Officer Senior Management 2019 67
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Viva Biotech Holdings key executives to enhance your sales strategy Gain insight into Viva Biotech Holdings key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?